Processa (NASDAQ: PCSA) CEO adds 1,843 shares in open-market buy

Processa Pharmaceuticals, Inc.'s CEO, George K. Ng, reported an open-market purchase of 1,843 shares of common stock at $2.97 per share on April 15, 2026. This transaction increased his direct holdings to 3,979 shares. The filing also disclosed indirect holdings through the Ng Cha Family Trust and a George Ng IRRA account.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin